SK Bioscience Financials
| 302440 Stock | 42,450 100.00 0.24% |
302440 |
Understanding current and past SK Bioscience Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of SK Bioscience's financial statements are interrelated, with each one affecting the others. For example, an increase in SK Bioscience's assets may result in an increase in income on the income statement.
Please note, the presentation of SK Bioscience's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, SK Bioscience's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of SK Bioscience's management manipulating its earnings.
| Foreign Associate | Korea |
| Instrument | Korea Stock View All |
| Exchange | Korea Stock Exchange |
| ISIN | KR7302440003 |
| Business Address | 310, Pangyo-ro, Seongnam-si, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.skbioscience.co.kr |
| Phone | 82 2 2008 2200 |
You should never invest in SK Bioscience without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of 302440 Stock, because this is throwing your money away. Analyzing the key information contained in SK Bioscience's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
SK Bioscience Key Financial Ratios
SK Bioscience's financial ratios allow both analysts and investors to convert raw data from SK Bioscience's financial statements into concise, actionable information that can be used to evaluate the performance of SK Bioscience over time and compare it to other companies across industries.| Return On Equity | 0.18 | |||
| Return On Asset | 0.11 | |||
| Target Price | 82083.0 | |||
| Z Score | 93.6 |
302440 Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining SK Bioscience's current stock value. Our valuation model uses many indicators to compare SK Bioscience value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across SK Bioscience competition to find correlations between indicators driving SK Bioscience's intrinsic value. More Info.SK Bioscience Co is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.63 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for SK Bioscience Co is roughly 1.59 . Comparative valuation analysis is a catch-all model that can be used if you cannot value SK Bioscience by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for SK Bioscience's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.SK Bioscience Systematic Risk
SK Bioscience's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. SK Bioscience volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on SK Bioscience correlated with the market. If Beta is less than 0 SK Bioscience generally moves in the opposite direction as compared to the market. If SK Bioscience Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one SK Bioscience is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of SK Bioscience is generally in the same direction as the market. If Beta > 1 SK Bioscience moves generally in the same direction as, but more than the movement of the benchmark.
SK Bioscience March 23, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of SK Bioscience help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of SK Bioscience Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of SK Bioscience Co based on widely used predictive technical indicators. In general, we focus on analyzing 302440 Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build SK Bioscience's daily price indicators and compare them against related drivers.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 11.93 | |||
| Value At Risk | (4.35) | |||
| Potential Upside | 2.94 |
Complementary Tools for 302440 Stock analysis
When running SK Bioscience's price analysis, check to measure SK Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SK Bioscience is operating at the current time. Most of SK Bioscience's value examination focuses on studying past and present price action to predict the probability of SK Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SK Bioscience's price. Additionally, you may evaluate how the addition of SK Bioscience to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |